Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 438-444 |
Journal | Alzheimers & Dementia |
Volume | 9 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2013 |
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
B. Vellas, M.C. Carrillo, C. Sampaio, H.R. Brashear, E. Siemers, H. Hampel, L.S. Schneider, M. Weiner, R. Doody, Z. Khachaturian, J. Cedarbaum, M. Grundman, K. Broich, E. Giacobini, B Dubois, R. Sperling, G.K. Wilcock, N.C. Fox, P. Scheltens, J. Touchon
Research output: Contribution to journal › Article › Academic › peer-review